{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:13:00Z","timestamp":1791421980704,"version":"4.3.3"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA043691"],"award-info":[{"award-number":["R01 DA043691"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA42146"],"award-info":[{"award-number":["R01 DA42146"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA036541"],"award-info":[{"award-number":["R01 DA036541"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA031160"],"award-info":[{"award-number":["R01 DA031160"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Survey on Drug Use and Health"},{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000058","name":"SAMHSA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate age-based differences in prescription opioid misuse (POM) motives and to evaluate substance use and mental and physical health correlates of POM motive categories in older adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Data were from the National Survey on Drug Use and Health (NSDUH), a nationally representative US survey.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>The NSDUH is a household survey.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects<\/jats:title>\n                  <jats:p>A total of 5,826 US residents with past-year POM; 415 were 50\u2009years and older (7.1%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Nine POM motives were assessed among those engaged in past-year POM, grouped into three categories: solely physical pain relief, solely non\u2013pain relief, or mixed motives. Prevalence of POM motives were calculated by age group, with logistic models examining age-based differences. Finally, odds of substance use and mental and physical health correlates by motive category were calculated via logistic models in older adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>POM motivated solely by physical pain relief increased from 35.1% in young adults to 65.4% in older adults; in older adults, 84.7% of POM episodes involved pain relief as a motive. POM for solely non\u2013pain relief or mixed motives was associated with greater odds, vs pain relief only, of past-year benzodiazepine misuse (odds ratio [OR] = 4.43 and 6.15, respectively), any substance use disorder (OR = 5.57 and 5.60, respectively), and suicidal ideation (OR = 4.05 and 3.56, respectively) in older adults.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>. POM motives change over the lifespan, with increasing POM for pain relief with aging. Comprehensive nonopioid pain management is needed for those engaged in POM for pain relief, and substance use and mental health treatment are needed for those with non\u2013pain relief motives.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnz304","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T19:38:03Z","timestamp":1571341083000},"page":"2237-2243","source":"Crossref","is-referenced-by-count":46,"title":["Prescription Opioid Misuse Motives in US Older Adults"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3655-0496","authenticated-orcid":false,"given":"Ty S","family":"Schepis","sequence":"first","affiliation":[{"name":"Department of Psychology, Texas State University, San Marcos, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wastila","sequence":"additional","affiliation":[{"name":"Peter Lamy Center on Drug Therapy and Aging, and Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Ammerman","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita V","family":"McCabe","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan"},{"name":"St. Joseph Mercy Ann Arbor, St. Joseph Mercy Health System, Ypsilanti, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean Esteban","family":"McCabe","sequence":"additional","affiliation":[{"name":"Center for the Study of Drugs, Alcohol, Smoking and Health, School of Nursing, University of Michigan, Ann Arbor, Michigan"},{"name":"Institute for Research on Women and Gender, University of Michigan, Ann Arbor, Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan"},{"name":"Center for Human Growth and Development, University of Michigan, Ann Arbor, Michigan, USA"},{"name":"Center for Human Growth and Development, University of Michigan, Ann Arbor, Michigan,\u2009USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"issue":"5152","key":"2020102904111227800_pnz304-B1","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths-United States","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020102904111227800_pnz304-B2","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53)","year":"2018"},{"key":"2020102904111227800_pnz304-B3","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11973","article-title":"Correlates of prescription opioid use, misuse, use disorders, and motivations for misuse among US adults","author":"Han","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"2020102904111227800_pnz304-B4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jagp.2016.06.003","article-title":"A systematic review of opioid and benzodiazepine misuse in older adults","volume":"24","author":"Maree","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"issue":"8","key":"2020102904111227800_pnz304-B5","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/j.pain.0000000000001241","article-title":"Sources of opioid medication for misuse in older adults: Results from a nationally representative survey","volume":"159","author":"Schepis","year":"2018","journal-title":"Pain"},{"key":"2020102904111227800_pnz304-B6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.addbeh.2016.04.020","article-title":"Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002-2003 and 2012-2013 National Survey on Drug Use and Health","volume":"60","author":"Schepis","year":"2016","journal-title":"Addict Behav"},{"key":"2020102904111227800_pnz304-B7","year":"2017"},{"issue":"8","key":"2020102904111227800_pnz304-B8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpediatrics.2009.120","article-title":"Motives for nonmedical use of prescription opioids among high school seniors in the United States: Self-treatment and beyond","volume":"163","author":"McCabe","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2020102904111227800_pnz304-B9","year":"2019"},{"key":"2020102904111227800_pnz304-B10","year":"2017"},{"key":"2020102904111227800_pnz304-B11","volume-title":"Estimation of Sampling Errors for Complex Survey Data","author":"Yansaneh","year":"2003"},{"key":"2020102904111227800_pnz304-B12","author":"Lipari"},{"issue":"5","key":"2020102904111227800_pnz304-B13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jadohealth.2012.02.004","article-title":"Motivational subtypes of nonmedical use of prescription medications: Results from a national study","volume":"51","author":"McCabe","year":"2012","journal-title":"J Adolesc Health"},{"issue":"1","key":"2020102904111227800_pnz304-B14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/gps.4999","article-title":"Prescription opioid and benzodiazepine misuse is associated with suicidal ideation in older adults","volume":"34","author":"Schepis","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"key":"2020102904111227800_pnz304-B15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addbeh.2015.06.006","article-title":"Prescription pain reliever misuse prevalence, correlates, and origin of possession throughout the life course","volume":"50","author":"Mowbray","year":"2015","journal-title":"Addict Behav"},{"key":"2020102904111227800_pnz304-B16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3109\/10826088309033049","article-title":"Reliability and consistency in self-reports of drug use","volume":"18","author":"O\u2019Malley","year":"1983","journal-title":"Int J Addict"},{"key":"2020102904111227800_pnz304-B17","first-page":"31","article-title":"Issues of validity and population coverage in student surveys of drug use","volume":"57","author":"Johnston","year":"1985","journal-title":"NIDA Res Monogr"},{"key":"2020102904111227800_pnz304-B18","year":"2014"},{"key":"2020102904111227800_pnz304-B19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.drugalcdep.2018.07.006","article-title":"Marijuana use by middle-aged and older adults in the United States, 2015-2016","volume":"191","author":"Han","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"2020102904111227800_pnz304-B20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/ajad.12598","article-title":"Nonmedical versus medical marijuana use among three age groups of adults: Associations with mental and physical health status","volume":"26","author":"Choi","year":"2017","journal-title":"Am J Addict"},{"key":"2020102904111227800_pnz304-B21","first-page":"2333721419843707.","article-title":"Patterns of marijuana use and health impact: A survey among older Coloradans","volume":"5","author":"Lum","year":"2019","journal-title":"Gerontol Geriatr Medi"},{"key":"2020102904111227800_pnz304-B22","author":"Cunningham"},{"issue":"15","key":"2020102904111227800_pnz304-B23","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"2020102904111227800_pnz304-B24","first-page":"CD007407","article-title":"Psychological therapies for the management of chronic pain (excluding headache) in adults","volume":"11","author":"Williams","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2020102904111227800_pnz304-B25","first-page":"CD003971.","article-title":"Methadone for cancer pain","volume":"2","author":"Nicholson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2020102904111227800_pnz304-B26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00325481.2017.1270699","article-title":"Safety of buprenorphine transdermal system in the management of pain in older adults","volume":"129","author":"Pergolizzi","year":"2017","journal-title":"Postgrad Med"},{"issue":"3","key":"2020102904111227800_pnz304-B27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bmjspcare-2015-000939","article-title":"The effectiveness of buprenorphine for treating cancer pain: An abridged Cochrane review","volume":"6","author":"Schmidt-Hansen","year":"2016","journal-title":"BMJ Support Palliat Care"},{"issue":"1","key":"2020102904111227800_pnz304-B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10550887.2014.975617","article-title":"Diversion of methadone and buprenorphine from opioid substitution treatment: Patients who regularly sell or share their medication","volume":"34","author":"Johnson","year":"2015","journal-title":"J Addict Dis"},{"key":"2020102904111227800_pnz304-B29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.drugalcdep.2017.06.033","article-title":"Abuse liability of intravenous buprenorphine vs. buprenorphine\/naloxone: Importance of absolute naloxone amount","volume":"179","author":"Jones","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"2020102904111227800_pnz304-B30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J Addict Med"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/21\/10\/2237\/34050717\/pnz304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/painmedicine\/article-pdf\/21\/10\/2237\/34050717\/pnz304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T08:11:44Z","timestamp":1603959104000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/21\/10\/2237\/5670776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,12,9]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnz304","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2019,12,9]]}}}